XML 38 R26.htm IDEA: XBRL DOCUMENT v3.19.2
Quarterly Financial Information (Unaudited)
 12 Months Ended
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information (Unaudited)
Quarterly Financial Information (Unaudited)
 
First
 
Second
 
Third
 
Fourth
 
 
In millions, except per share amounts
Quarter
 
Quarter
 
Quarter
 
Quarter
 
Year
2018:
 
 
 
 
 
 
 
 
 
Total revenues (1)
$
45,743

 
$
46,922

 
$
47,490

 
$
54,424

 
$
194,579

Operating income (loss) (1)
1,996

 
(1,373
)
 
2,574

 
824

 
4,021

Income (loss) from continuing operations
998

 
(2,562
)
 
1,390

 
(422
)
 
(596
)
Net income (loss) attributable to CVS Health
998

 
(2,563
)
 
1,390

 
(419
)
 
(594
)
Per common share data:
 
 
 
 
 
 
 
 
 
Basic earnings (loss) per common share:
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations attributable to CVS Health
$
0.98

 
$
(2.52
)
 
$
1.36

 
$
(0.37
)
 
$
(0.57
)
Income (loss) from discontinued operations attributable to CVS Health
$
—

 
$
—

 
$
—

 
$
—

 
$
—

Net income (loss) attributable to CVS Health
$
0.98

 
$
(2.52
)
 
$
1.36

 
$
(0.37
)
 
$
(0.57
)
Diluted earnings (loss) per common share:
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations attributable to CVS Health
$
0.98

 
$
(2.52
)
 
$
1.36

 
$
(0.37
)
 
$
(0.57
)
Income (loss) from discontinued operations attributable to CVS Health
$
—

 
$
—

 
$
—

 
$
—

 
$
—

Net income (loss) attributable to CVS Health
$
0.98

 
$
(2.52
)
 
$
1.36

 
$
(0.37
)
 
$
(0.57
)
Dividends per common share
$
0.50

 
$
0.50

 
$
0.50

 
$
0.50

 
$
2.00

 
 
 
 
 
 
 
 
 
 
_____________________________________________ 
(1)
Effective for the fourth quarter of 2018, interest income was reclassified from interest expense, net to net investment income within revenues to conform with insurance company presentation. Accordingly, a retrospective reclassification of $50 million, $214 million and $221 million was made for the first, second and third quarters of 2018, respectively, to increase revenues and increase interest expense.
 
First
    
Second
    
Third
    
Fourth
    
 
In millions, except per share amounts
Quarter
 
Quarter
 
Quarter
 
Quarter
 
Year
2017:
 
 
 
 
 
 
 
 
 
Total revenues (1)
$
44,520

 
$
45,689

 
$
46,186

 
$
48,391

 
$
184,786

Operating income (1)
1,799

 
2,121

 
2,504

 
3,114

 
9,538

Income from continuing operations
962

 
1,097

 
1,285

 
3,287

 
6,631

Net income attributable to CVS Health
952

 
1,098

 
1,285

 
3,287

 
6,622

Per common share data:
 
 
 
 
 
 
 
 
 
Basic earnings per common share:
 
 
 
 
 
 
 
 
 
Income from continuing operations attributable to CVS Health
$
0.93

 
$
1.07

 
$
1.26

 
$
3.23

 
$
6.48

Income (loss) from discontinued operations attributable to CVS Health
$
(0.01
)
 
$
—

 
$
—

 
$
—

 
$
(0.01
)
Net income attributable to CVS Health
$
0.92

 
$
1.07

 
$
1.26

 
$
3.23

 
$
6.47

Diluted earnings per common share:
 
 
 
 
 
 
 
 
 
Income from continuing operations attributable to CVS Health
$
0.92

 
$
1.07

 
$
1.26

 
$
3.22

 
$
6.45

Income (loss) from discontinued operations attributable to CVS Health
$
(0.01
)
 
$
—

 
$
—

 
$
—

 
$
(0.01
)
Net income attributable to CVS Health
$
0.92

 
$
1.07

 
$
1.26

 
$
3.22

 
$
6.44

Dividends per common share
$
0.50

 
$
0.50

 
$
0.50

 
$
0.50

 
$
2.00

 
 
 
 
 
 
 
 
 
 
_____________________________________________ 
(1)
Effective for the fourth quarter of 2018, interest income was reclassified from interest expense, net to net investment income within revenues to conform with insurance company presentation. Accordingly, a retrospective reclassification of $6 million, $4 million, $5 million and $6 million was made for the first, second, third and fourth quarters of 2017, respectively, to increase revenues and increase interest expense.